Skip to content

Establishment and Implementation of Early Identification and Disease Prognosis Models for Adolescents with Tardive Dyskinesia

Establishment and Implementation of Early Identification and Disease Prognosis Models for Adolescents with Tardive Dyskinesia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104746
Enrollment
Unknown
Registered
2025-06-23
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tardive dyskinesia

Interventions

Tardive dyskinesia group:NA
Non tardive dyskinesia group:NA

Sponsors

Peking University Sixth Hospital ( Institute of Mental Health )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 19 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for the TD Group: 1. Age: 12–19 years; 2. Medication History: At least 3 months of prior use of medications associated with TD (e.g., antidepressants, antipsychotics, calcium channel blockers, or other TD-inducing drugs); 3. Symptom Assessment for TD Group: Must meet the criteria assessed by the Abnormal Involuntary Movement Scale (AIMS), defined as either: Moderate involuntary movements (AIMS score >=3) in at least one body region, or Mild involuntary movements (AIMS score >=2) in at least two body regions; 4. Informed Consent: Voluntarily sign the informed consent form and agree to participate in the study. Inclusion Criteria for the Non-TD Group: 1. Age: 12–19 years; 2. Medication History: At least 3 months of prior use of medications associated with TD (e.g., antidepressants, antipsychotics, calcium channel blockers, or other TD-inducing drugs); 3. Symptom Exclusion: No involuntary movements observed in any body region during medication use; 4. Informed Consent: Voluntarily sign the informed consent form and agree to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Exclusion of other conditions that may cause involuntary movements, such as hereditary dystonia, Huntington’s chorea, Sydenham’s chorea, or similar disorders; 2. Individuals unable to complete genetic testing, imaging studies, or scale assessments due to intellectual disability, severe physical illness, or other limiting conditions.

Design outcomes

Primary

MeasureTime frame
Abnormal Involuntary Movement Scale, AIMS;Clinical Global Impression Scale, CGI;

Secondary

MeasureTime frame
Positive and Negative Syndrome Scale, PANSS;Neuropsychiatric Inventory, NPI;Hamilton Depression Scale, HAMD;Brief Psychiatric Rating Scale, BPRS;Extrapyramidal Symptom Rating Scale, ESRS;Tardive Dyskinesia Rating Scale, TDRS;Montreal Cognitive Assessment, MoCA;Mini-mental State Examination, MMSE;

Countries

China

Contacts

Public ContactBai Chaobo

Peking University Sixth Hospital ( Institute of Mental Health )

prodigybcb@bjmu.edu.cn+86 10 62723886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026